Predictive Value of Plasma D-dimer Levels in Patients with Advanced Non-small-cell Lung Cancer

Overview

Journal Onco Targets Ther

Publisher Dove Medical Press

Specialty Oncology

Date 2015 May 1

PMID 25926741

Citations 17

Authors

Yuezhen Wang

Zhun Wang

Affiliations

Soon will be listed here.

Abstract

Purpose: The relationship between plasma D-dimer level and the prognosis of advanced non-small-cell lung cancer (NSCLC) is not well studied. This study investigated the role of plasma D-dimer as a prognostic factor in advanced NSCLC.

Methods: The plasma D-dimer was measured in 1,931 newly diagnosed advanced NSCLC patients by enzyme-linked immunosorbent assay. Correlations between plasma D-dimer levels and other clinical parameters were analyzed. Survival curves were plotted using the Kaplan-Meier method. The Cox proportional hazard model was used for multivariate analysis.

Results: Plasma D-dimer concentrations were within the normal range in 1,393 patients (72.1%) and elevated in 538 patients (27.9%). The median overall survival was 11.5 and 8.8 months in the normal and high plasma D-dimer group, respectively (P<0.001). The progression-free survival of first-line chemotherapy was 5.0 months and 4.4 months in the groups with normal and high levels of plasma D-dimer, respectively, (P<0.001). By multivariate analyses, the elevated plasma D-dimer level was found to be an independent prognostic factor for poor survival (hazard ratio =1.245; P<0.001).

Conclusion: Plasma D-dimer is an independent determinant of poor prognosis in advanced NSCLC.

Citing Articles

A novel prognostic score of recurrence for endometrial cancer patients with staging surgery.

Maehana T, Kawahara N, Kamibayashi J, Matsuoka M, Waki K, Kawaguchi R BMC Womens Health. 2024; 24(1):671.

PMID: 39734204 PMC: 11684112. DOI: 10.1186/s12905-024-03528-8.

Association of baseline plasma D-dimer and platelets with progression-free survival in patients with stage IV non-small cell lung cancer treated with anti-PD-1 antibody.

Pang B, Wang J, Zhang J, Ren X, Han Y Transl Lung Cancer Res. 2024; 13(11):3106-3121.

PMID: 39670021 PMC: 11632421. DOI: 10.21037/tlcr-24-763.

Prognostic value of plasma D-dimer levels in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: a retrospective study.

Li X, Lu D, Zhang Z, Zhang Y, Wang J, Hu Y J Thorac Dis. 2022; 14(10):4125-4135.

PMID: 36389301 PMC: 9641356. DOI: 10.21037/jtd-22-1363.

Coagulation parameters in lung cancer patients: A systematic review and meta-analysis.

Bayleyegn B, Adane T, Getawa S, Aynalem M, Kifle Z J Clin Lab Anal. 2022; 36(7):e24550.

PMID: 35719003 PMC: 9279983. DOI: 10.1002/jcla.24550.

Circulating D-Dimers Increase the Risk of Mortality and Venous Thromboembolism in Patients With Lung Cancer: A Systematic Analysis Combined With External Validation.

Li J, Yan S, Zhang X, Xiang M, Zhang C, Gu L Front Med (Lausanne). 2022; 9:853941.

PMID: 35308559 PMC: 8924589. DOI: 10.3389/fmed.2022.853941.

References

Dirix L, Salgado R, Weytjens R, Colpaert C, Benoy I, Huget P . Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer. Br J Cancer. 2002; 86(3):389-95. PMC: 2375200. DOI: 10.1038/sj.bjc.6600069. View

Buccheri G, Torchio P, Ferrigno D . Plasma levels of D-dimer in lung carcinoma: clinical and prognostic significance. Cancer. 2003; 97(12):3044-52. DOI: 10.1002/cncr.11432. View

Unsal E, Atalay F, Atikcan S, Yilmaz A . Prognostic significance of hemostatic parameters in patients with lung cancer. Respir Med. 2004; 98(2):93-8. DOI: 10.1016/j.rmed.2003.07.001. View

Blackwell K, Hurwitz H, Lieberman G, Novotny W, Snyder S, Dewhirst M . Circulating D-dimer levels are better predictors of overall survival and disease progression than carcinoembryonic antigen levels in patients with metastatic colorectal carcinoma. Cancer. 2004; 101(1):77-82. DOI: 10.1002/cncr.20336. View

Antoniou D, Pavlakou G, Stathopoulos G, Karydis I, Chondrou E, Papageorgiou C . Predictive value of D-dimer plasma levels in response and progressive disease in patients with lung cancer. Lung Cancer. 2006; 53(2):205-10. DOI: 10.1016/j.lungcan.2006.03.015. View

Altiay G, Ciftci A, Demir M, Kocak Z, Sut N, Tabakoglu E . High plasma D-dimer level is associated with decreased survival in patients with lung cancer. Clin Oncol (R Coll Radiol). 2007; 19(7):494-8. DOI: 10.1016/j.clon.2007.04.002. View

Knowlson L, Bacchu S, Paneesha S, McManus A, Randall K, Rose P . Elevated D-dimers are also a marker of underlying malignancy and increased mortality in the absence of venous thromboembolism. J Clin Pathol. 2010; 63(9):818-22. DOI: 10.1136/jcp.2010.076349. View

Raj S, Zhou X, Bueso-Ramos C, Ravi V, Patel S, Benjamin R . Prognostic significance of elevated D-dimer for survival in patients with sarcoma. Am J Clin Oncol. 2011; 35(5):462-7. DOI: 10.1097/COC.0b013e31821d4529. View

Komurcuoglu B, Ulusoy S, Gayaf M, Guler A, Ozden E . Prognostic value of plasma D-dimer levels in lung carcinoma. Tumori. 2012; 97(6):743-8. DOI: 10.1177/030089161109700611. View

10.

Zhou Y, Yang Z, Feng J, Shan Y, Wang W, Mei Y . High plasma D-dimer level is associated with decreased survival in patients with lung cancer: a meta-analysis. Tumour Biol. 2013; 34(6):3701-4. DOI: 10.1007/s13277-013-0953-2. View

11.

Ma X, Li Y, Zhang J, Huang J, Liu L . Prognostic role of D-dimer in patients with lung cancer: a meta-analysis. Tumour Biol. 2013; 35(3):2103-9. DOI: 10.1007/s13277-013-1279-9. View

12.

Wang Z, Fu J, Diao D, Dang C . Plasma D-dimer level in the perioperative period in non-small-cell lung cancer. Thorac Cancer. 2011; 2(4):207-212. DOI: 10.1111/j.1759-7714.2011.00055.x. View

13.

Gabazza E, Taguchi O, Yamakami T, Machishi M, Ibata H, Suzuki S . Evaluating prethrombotic state in lung cancer using molecular markers. Chest. 1993; 103(1):196-200. DOI: 10.1378/chest.103.1.196. View

14.

De Buyzere M, Philippe J, Duprez D, Baele G, Clement D . Coagulation system activation and increase of D-dimer levels in peripheral arterial occlusive disease. Am J Hematol. 1993; 43(2):91-4. DOI: 10.1002/ajh.2830430204. View

15.

Taguchi O, Gabazza E, Yasui H, Kobayashi T, Yoshida M, Kobayashi H . Prognostic significance of plasma D-dimer levels in patients with lung cancer. Thorax. 1997; 52(6):563-5. PMC: 1758583. DOI: 10.1136/thx.52.6.563. View